Kontrol Announces Funding to Accelerate the Development of Kontrol BioWater, a Real-Time Viral Testing Technology
TORONTO--(BUSINESS WIRE)--Kontrol Technologies Corp. (NEO:KNR) (OTCQB:KNRLF) (FSE:1K8) (“Kontrol” or the “Company”) announces that its operating subsidiary - CEM Specialties Inc. - is receiving advisory services and funding of up to $300,000 from